RSV and the flu have taken hold as Chicago residents have partaken in festivities in the last several weeks, and COVID is ...

Researchers have shown that people 60 years or older with weakened immunity do not respond as strongly to vaccines against the respiratory syncytial virus (RSV) as people in the same age group with ...

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity—primarily organ transplant ...

Discover CDC findings on COVID-19 variants and vaccine protection, revealing key insights into emerging strains and public ...

At the same time, the expiration of key patents is coming up for some major Pfizer drugs, including blood thinner Eliquis and ...

Symptoms of respiratory syncytial virus, or RSV, may start off similar to a common cold, with sneezing and a runny nose. But ...

The global response to the COVID-19 pandemic has been characterized by a massive rollout of vaccines aimed at curbing the ...

Whether the next pandemic is caused by H5N1 bird flu or something else, we must prepare now to use convalescent plasma to ...

AI stocks are stealing the spotlight today as the appetite for these services continues to gain traction globally.

Tiziana Life Sciences develops foralumab for treating neurodegenerative diseases like SPMS and Alzheimer's, with promising ...